图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Roles of Smad3 in TGF-β Signaling During Carcinogenesis

卷 17, 册 4, 2007, pp. 281-293
DOI: 10.1615/CritRevEukarGeneExpr.v17.i4.30
Get accessGet access

摘要

Signaling of transforming growth factor β (TGF-β) is mediated through a heteromeric complex of two types of transmembrane receptors and downstream intracellular proteins known as Smads. Alterations of TGF-β signaling underlie various forms of human cancer and developmental diseases. Human genetic studies have revealed both point mutations and deletions of Smad2 or Smad4 in several types of cancers. However, the role of Smad3 in tumorigenesis is not clear. Recent data indicate that Smad3 also functions as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis. In addition, Smad3 is essential for TGF-β-mediated immune suppression, and it plays an important role in regulating transcriptional responses that are favorable to metastasis. Therefore, through regulating different transcriptional responses, Smad3 functions as both a negative and positive regulator of carcinogenesis depending on cell type and clinical stage of the tumor.

对本文的引用
  1. Kim Seok-Hyung, Ahn Soomin, Park Cheol-Keun, Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy, Hepatobiliary & Pancreatic Diseases International, 11, 1, 2012. Crossref

  2. Gulubova Maya, Ananiev Julian, Yovchev Yovchev, Julianov Aleksander, Karashmalakov Anatoli, Vlaykova Tatyana, The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients’ survival, Journal of Molecular Histology, 44, 6, 2013. Crossref

  3. Gulubova Maya, Manolova Irena, Ananiev Julian, Kjurkchiev Dobroslav, Julianov Alexander, Altunkova Iskra, Relationship of TGF-β1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis, APMIS, 121, 10, 2013. Crossref

  4. Deng Xiyun, Cao Yanna, Liu Yan, Li Fazhi, Sambandam Kamalanathan, Rajaraman Srinivasan, Perkins Archibald S., Fields Alan P., Hellmich Mark R., Townsend Courtney M., Thompson E. Aubrey, Ko Tien C., Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer, Molecular Carcinogenesis, 52, 4, 2013. Crossref

  5. Krstic Jelena, Santibanez Juan F., Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-Infiltrating Myeloid Cells, The Scientific World Journal, 2014, 2014. Crossref

  6. Danielsson K., Wahlin Y. B., Coates P. J., Nylander K., Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa, Journal of Oral Pathology & Medicine, 39, 8, 2010. Crossref

  7. Qie Shuo, Sang Nianli, Release the ink4a/arf growth suppression by “u” and “me”?, Cell Cycle, 10, 2, 2011. Crossref

  8. Yuan FangJun, Zhou Wenbo, Zou Can, Zhang Zhiyun, Hu Hongsheng, Dai Zongqing, Zhang YouShun, Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways, Molecular and Cellular Biochemistry, 343, 1-2, 2010. Crossref

  9. Zhang L., Li Q.X., Wu H.L., Lu X., Yang M., Yu S.Y., Yuan X.L., SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib, Annals of Oncology, 25, 8, 2014. Crossref

  10. Watanabe S., Misawa M., Matsuzaki T., Sakurai T., Muramatsu T., Sato M., A novel glycosylation signal regulates transforming growth factor   receptors as evidenced by endo- -galactosidase C expression in rodent cells, Glycobiology, 21, 4, 2011. Crossref

  11. Tokay Esra, Kockar Feray, Identification of intracellular pathways through which TGF-β1 upregulates URG-4/URGCP gene expression in hepatoma cells, Life Sciences, 144, 2016. Crossref

  12. Xue Jian-Fei, Hua Fang, Lv Qi, Lin Heng, Wang Zi-Yan, Yan Jun, Liu Jin-Wen, Lv Xiao-Xi, Yang Hong-Zhen, Hu Zhuo-Wei, DEDD negatively regulates transforming growth factor-β1 signaling by interacting with Smad3, FEBS Letters, 584, 14, 2010. Crossref

  13. Li Zhenye, Liu Qian, Li Chuzhong, Zong Xuyi, Bai Jiwei, Wu Youtu, Lan Xiaolei, Yu Guoqiang, Zhang Yazhuo, The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas, Molecular and Cellular Endocrinology, 402, 2015. Crossref

  14. Johnson Mahlon D., Shaw Aubie K., O’Connell Mary J., Sim Fraser J., Moses Harold L., Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas, Journal of Neuro-Oncology, 103, 2, 2011. Crossref

  15. Yao Bing, Zhao Jinsheng, Li Yalin, Li Hui, Hu Zhaojun, Pan Pan, Zhang Yiran, Du E., Liu Ranlu, Xu Yong, Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation, The Prostate, 75, 8, 2015. Crossref

  16. Namazi Hamid, Practice Pearl: A Novel Use of Rifampicin for Treatment of Carpal Tunnel Syndrome, The Journal of Pain, 9, 4, 2008. Crossref

  17. Hu Haibo, Xu Zhenlei, Li Chang, Xu Chun, Lei Zhe, Zhang Hong-Tao, Zhao Jun, MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells, Lung Cancer, 97, 2016. Crossref

  18. Zhou Hong-Hao, Chen Lin, Liang Hui-Fang, Li Guang-Zhen, Zhang Bi-Xiang, Chen Xiao-Ping, Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT, International Journal of Molecular Sciences, 17, 4, 2016. Crossref

  19. Johnson Mahlon D., Transforming Growth Factor Beta Family in the Pathogenesis of Meningiomas, World Neurosurgery, 104, 2017. Crossref

  20. Zhu Haiping, Gui Qunfeng, Hui Xiaobo, Wang Xiaodong, Jiang Jian, Ding Lianshu, Sun Xiaoyang, Wang Yanping, Chen Huaqun, TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats, Medical Science Monitor, 23, 2017. Crossref

  21. Dimopoulos Konstantinos, Søgaard Helbo Alexandra, Fibiger Munch-Petersen Helga, Sjö Lene, Christensen Jesper, Sommer Kristensen Lasse, Asmar Fazila, Hermansen Niels Emil Ulrich, O'Connel Casey, Gimsing Peter, Liang Gangning, Grønbaek Kirsten, Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner, Molecular Oncology, 12, 2, 2018. Crossref

  22. SONG KAI, WU JUNHUA, JIANG CHUNPING, Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review), Oncology Reports, 29, 1, 2013. Crossref

  23. Kluth Oliver, Matzke Daniela, Kamitz Anne, Jähnert Markus, Vogel Heike, Scherneck Stephan, Schulze Matthias, Staiger Harald, Machicao Fausto, Häring Hans-Ulrich, Joost Hans-Georg, Schürmann Annette, Barsh Gregory S., Identification of Four Mouse Diabetes Candidate Genes Altering β-Cell Proliferation, PLOS Genetics, 11, 9, 2015. Crossref

  24. Tykwinska Karolina, Lauster Roland, Knaus Petra, Rosowski Mark, Deb Sumitra, Growth and Differentiation Factor 3 Induces Expression of Genes Related to Differentiation in a Model of Cancer Stem Cells and Protects Them from Retinoic Acid-Induced Apoptosis, PLoS ONE, 8, 8, 2013. Crossref

  25. Li Ming-Yi, Liu Jin-Quan, Chen Dong-Ping, Li Zhou-Yu, Qi Bin, He Lu, Yu Yi, Yin Wen-Jin, Wang Meng-Yao, Lin Ling, Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways, Cancer Biology & Therapy, 18, 9, 2017. Crossref

  26. Yu Yunhu, Li Jindie, Zhou Hang, Xiong Yanquan, Wen Yuanchao, Li Hang, Functional importance of the TGF-β1/Smad3 signaling pathway in oxygen-glucose-deprived (OGD) microglia and rats with cerebral ischemia, International Journal of Biological Macromolecules, 116, 2018. Crossref

  27. Zhou Shujuan, Xu Bo, Qi Liang, Zhu Dongqin, Liu Baorui, Wei Jia, Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient, Cancer Biology & Therapy, 20, 1, 2019. Crossref

  28. Lim Kia Hui, Cross-Talk Between Cell Mechanics and Biochemical Signalling Pathways via Modulation of Nucleocytoplasmic Shuttling of Transcription Factors: A Novel Approach to Study Fibroblasts in Breast Cancer Environments, in IRC-SET 2018, 2019. Crossref

  29. Lu Zhufeng, Li Xiuhua, Xu Yongfeng, Chen Miaomiao, Chen Wei, Chen Tao, Tang Qinghe, He Zhiying, microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma, Cell Death & Disease, 10, 10, 2019. Crossref

  30. Abedini Bakhshmand Elham, Soltani Bahram Mohammad, Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts, Biological Chemistry, 400, 5, 2019. Crossref

  31. Nayyar Gaurav, Chu Yaya, Cairo Mitchell S., Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors, Frontiers in Oncology, 9, 2019. Crossref

  32. Han Gangwen, Han Zheyi, Wang Xiao-Jing, TGF-β in Skin Cancer and Fibrosis, in TGF-β in Human Disease, 2013. Crossref

  33. Ooshima Akira, Park Jinah, Kim Seong‐Jin, Phosphorylation status at Smad3 linker region modulates transforming growth factor‐β‐induced epithelial‐mesenchymal transition and cancer progression, Cancer Science, 110, 2, 2019. Crossref

  34. Kozuevanich Sivakorn, Meechai Asawin, Chan Jonathan H., Biomarker Identification in Colorectal Cancer Using Subnetwork Analysis with Feature Selection, in Recent Advances in Information and Communication Technology 2020, 1149, 2020. Crossref

  35. Alyaseer Amani Abraheem Alsadiq, de Lima Murilo Henrique Saturnino, Braga Tarcio Teodoro, The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis, Frontiers in Immunology, 11, 2020. Crossref

  36. Ding Hanyan, Fang Meng, Gong Yongfang, Li Dong, Zhang Chong, Wen Guanghua, Wu Chao, Yang Jingjing, Yang Yan, Smad3 gene C‐terminal phosphorylation site mutation aggravates CCl 4 ‐induced inflammation in mice , Journal of Cellular and Molecular Medicine, 24, 12, 2020. Crossref

  37. Guan Xu, Yi Ying, Huang Yan, Hu Yongfei, Li Xiaobo, Wang Xishan, Fan Huihui, Wang Guiyu, Wang Dong, Revealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy, Oncotarget, 6, 35, 2015. Crossref

  38. Ren Liying, Liu Wenqin, Wang Chengliang, Yang Yifan, Huang Xiaoqian, Wang Chunxia, Li Yuhao, The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats, Journal of Ethnopharmacology, 254, 2020. Crossref

  39. Shepard Alyssa, Kissil Joseph L., The use of non-traditional models in the study of cancer resistance—the case of the naked mole rat, Oncogene, 39, 28, 2020. Crossref

  40. Olkhov-Mitsel Ekaterina, Hodgson Anjelica, Liu Stanley K, Vesprini Danny, Bayani Jane, Bartlett John, Xu Bin, Downes Michelle R, Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study, Journal of Clinical Pathology, 74, 1, 2021. Crossref

  41. Chen Xiaonan, Zhao Yanan, Yang Ailin, Tian Yingying, Pang Daoran, Sun Jing, Tang Leimengyuan, Huang Huiming, Wang Ying, Zhao Yunfang, Tu Pengfei, Hu Zhongdong, Li Jun, Chinese Dragon’s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3, Frontiers in Pharmacology, 11, 2020. Crossref

  42. Zhang Yong‑Hui , Pan Lian‑Hong , Pang Yi , Yang Jin‑Xin , Lv Meng‑Jia , Liu Feng , Qu Xue‑Feng , Chen Xin‑Xin , Gong Hua‑Jun , Liu Dan , Wei Yong , GDF11/BMP11 as a novel tumor marker for liver cancer, Experimental and Therapeutic Medicine, 2018. Crossref

  43. Gong Yongfang, Li Dong, Li Lili, Yang Juan, Ding Hanyan, Zhang Chong, Wen Guanhua, Wu Chao, Fang Zhirui, Hou Shu, Yang Yan, Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis, Food and Chemical Toxicology, 147, 2021. Crossref

  44. De Mattia Elena, Canzonieri Vincenzo, Polesel Jerry, Mezzalira Silvia, Dalle Fratte Chiara, Dreussi Eva, Roncato Rossana, Bignucolo Alessia, Innocente Roberto, Belluco Claudio, Pucciarelli Salvatore, De Paoli Antonino, Palazzari Elisa, Toffoli Giuseppe, Cecchin Erika, SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy, Frontiers in Pharmacology, 12, 2021. Crossref

  45. Huang Zhao, Wen Jingyuan, Yu Jingjing, Liao Jingyu, Liu Sha, Cai Ning, Liang Huifang, Chen Xiaoping, Ding Zeyang, Zhang Bixiang, MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner, Journal of Experimental & Clinical Cancer Research, 39, 1, 2020. Crossref

  46. Zhi Lingtong, Su Xin, Yin Meichen, Zhang Zikang, Lu Hui, Niu Zhiyuan, Guo Changjiang, Zhu Wuling, Zhang Xuan, Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges, Cellular Immunology, 369, 2021. Crossref

  47. Durślewicz Justyna, Klimaszewska-Wiśniewska Anna, Jóźwicki Jakub, Antosik Paulina, Smolińska-Świtała Marta, Gagat Maciej, Kowalewski Adam, Grzanka Dariusz, Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non–Small-Cell Lung Cancer Patients, Cancer Control, 28, 2021. Crossref

  48. Fan Qi, Jian Yu, MiR-203a-3p regulates TGF-β1-induced epithelial–mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1, Bioscience Reports, 40, 2, 2020. Crossref

  49. Jahangiri Leila, Pucci Perla, Ishola Tala, Pereira Joao, Cavanagh Megan L., Turner Suzanne D., Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors, Discover Oncology, 12, 1, 2021. Crossref

  50. Chen Nanyue, Balasenthil Seetharaman, Reuther Jacquelyn, Killary Ann McNeill, DEAR1, a Novel Tumor Suppressor That Regulates Cell Polarity and Epithelial Plasticity, Cancer Research, 74, 20, 2014. Crossref

  51. Wang Qing-Ming, Tang Patrick Ming-Kuen, Lian Guang-Yu, Li Chunjie, Li Jinhong, Huang Xiao-Ru, To Ka-Fai, Lan Hui-Yao, Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells, Cancer Immunology Research, 6, 8, 2018. Crossref

  52. Ji Xiaoyu, Chu Guangdi, Chen Yulong, Jiao Jinwen, Lv Teng, Yao Qin, Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer, Archives of Gynecology and Obstetrics, 2022. Crossref

  53. Zelivianski Stanislav, Cooley Anne, Kall Ron, Jeruss Jacqueline S., Cyclin-Dependent Kinase 4–Mediated Phosphorylation Inhibits Smad3 Activity in Cyclin D–Overexpressing Breast Cancer Cells, Molecular Cancer Research, 8, 10, 2010. Crossref

  54. Chen Nanyue, Balasenthil Seetharaman, Reuther Jacquelyn, Frayna Aileen, Wang Ying, Chandler Dawn S., Abruzzo Lynne V., Rashid Asif, Rodriguez Jaime, Lozano Guillermina, Cao Yu, Lokken Erica, Chen Jinyun, Frazier Marsha L., Sahin Aysegul A., Wistuba Ignacio I., Sen Subrata, Lott Steven T., Killary Ann McNeill, DEAR1 Is a Chromosome 1p35 Tumor Suppressor and Master Regulator of TGF-β–Driven Epithelial–Mesenchymal Transition, Cancer Discovery, 3, 10, 2013. Crossref

  55. Zhang Chi, Ren Lin, Zhang Hongjian, Yang Shiwen, Deng Miao, He Lihong, Cao Ruoyan, Zhao Chuanjiang, Xia Juan, SESN1, negatively regulated by miR-377-3p, suppresses invasive growth of head and neck squamous cell carcinoma by interaction with SMAD3, Human Cell, 35, 4, 2022. Crossref

  56. Bae Eunjin, Sato Misako, Kim Ran-Ju, Kwak Mi-Kyung, Naka Kazuhito, Gim Jungsoo, Kadota Mitsutaka, Tang Binwu, Flanders Kathleen C., Kim Tae-Aug, Leem Sun-Hee, Park Taesung, Liu Fang, Wakefield Lalage M., Kim Seong-Jin, Ooshima Akira, Definition of Smad3 Phosphorylation Events That Affect Malignant and Metastatic Behaviors in Breast Cancer Cells, Cancer Research, 74, 21, 2014. Crossref

  57. Carey Mark S., Agarwal Roshan, Gilks Blake, Swenerton Kenneth, Kalloger Steve, Santos Jennifer, Ju Zhenlin, Lu Yiling, Zhang Fan, Coombes Kevin R., Miller Dianne, Huntsman David, Mills Gordon B., Hennessy Bryan T., Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy, Clinical Cancer Research, 16, 10, 2010. Crossref

  58. Dutta Diptavo, He Yuan, Saha Ashis, Arvanitis Marios, Battle Alexis, Chatterjee Nilanjan, Aggregative trans-eQTL analysis detects trait-specific target gene sets in whole blood, Nature Communications, 13, 1, 2022. Crossref

  59. Gomez Roshna Lawrence, Woods Laura M., Ramachandran Revathy, Abou Tayoun Ahmad N., Philpott Anna, Ali Fahad R., Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

  60. Mohamed Rasha M. S. M., Ahmad Enssaf Ahmad, Omran Bothina H. F., Sakr Amr T., Ibrahim Islam A. A. E.-H., Mahmoud Mona F., El-Naggar Mostafa E., Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor, Naunyn-Schmiedeberg's Archives of Pharmacology, 2022. Crossref

  61. Wu Yulian, Zhang Dandan, Ye Sheng, Liu Quanhui, Huang Ben, Parabolic relationship between SMAD3 expression level and the reprogramming efficiency of goat induced mammary epithelial cells, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

  62. Han Xiao, Tian Ruxian, Wang Cai, Li Yumei, Song Xicheng, CircRNAs: Roles in regulating head and neck squamous cell carcinoma, Frontiers in Oncology, 12, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain